India, June 2 -- Mullen Automotive, Inc. (MULN), Monday announced the acquisition of additional 21 percent stake in Bollinger Motors, Inc., bringing its total ownership to 95 percent in the Michigan-b... Read More
India, June 2 -- Clarivate Plc (CLVT), a global leader in transformative intelligence, has completed a $500 million upsize of its term loan B credit facility. This new tranche, maturing in 2031, carr... Read More
India, June 2 -- A reading on U.S. manufacturing activity unexpectedly edged slightly lower in the month of May, according to a report released by the Institute for Supply Management on Monday. The I... Read More
India, June 2 -- Herc Holdings Inc. (HRI), a top equipment rental supplier in North America, has completed the acquisition of H&E Equipment Services, Inc., operating as H&E Rentals. The deal strength... Read More
India, June 2 -- Microsoft (MSFT) has laid off hundreds of employees just weeks after its biggest round of job cuts in years. The company is working to reduce costs while continuing to invest heavily ... Read More
India, June 2 -- Retail sales in Cyprus continued to growth at a robust pace in April, albeit some easing, preliminary data from the statistical office Cystat showed on Monday. The volume of retail s... Read More
India, June 2 -- Unveiling the UK government's defence spending plans, Prime Minister Keir Starmer announced Monday that the country's military is moving towards "war-fighting readiness". Speaking in... Read More
India, June 2 -- Opus Genetics (IRD), Monday announced encouraging topline results from its pivotal Phase 3 LYNX-2 trial, evaluating Phentolamine Ophthalmic Solution 0.75 percent for chronic night dri... Read More
India, June 2 -- The Brazilian manufacturing economy deteriorated for the first time in more than two years in May amid demand retrenchment, survey data from S&P Global showed on Monday. The purchasi... Read More
India, June 2 -- Shares of Opus Genetics, Inc. (IRD) gained over 20% on Monday morning after the company announced positive topline results from LYNX-2, a pivotal Phase 3 clinical trial evaluating Phe... Read More